You just read:

Bayer Receives U.S. FDA Approval for Xofigo® (radium Ra 223 dichloride) Injection as a New Treatment for Castration-Resistant Prostate Cancer with Bone Metastases

News provided by

Bayer HealthCare Pharmaceuticals Inc.

May 15, 2013, 11:40 ET